Coronavirus vaccine testing on human to begin in September: Johnson & Johnson

Johnson & Johnson said that human testing of its experimental vaccine for the coronavirus would start by September and that it could be available for emergency use authorization in early 2021.

J&J  along with U.S. agency Biomedical Advanced Research and Development Authority had committed more than $1 billion of investment along with U.S. agency Biomedical Advanced Research and Development Authority to co-fund vaccine research.